Rhythm Pharmaceuticals
The Scientific Affairs Manager will provide scientific and medical leadership for rare MC4R pathway diseases in the UK, collaborating with national and international Medical Affairs teams to implement integrated tactical plans. The role involves building peer-to-peer relationships with Key External Experts, delivering clinical and scientific education, and supporting research initiatives and advisory boards. This position requires upholding the highest standards of compliance and scientific integrity while advancing medical and scientific initiatives.
Headquarters
Boston, Massachusetts, United States
Company Size
51-200 employees
Founded
2008
Rhythm Pharmaceuticals is a global biopharmaceutical company dedicated to transforming the lives of patients with rare neuroendocrine diseases by developing precision medicines that address the root cause. Its lead program, setmelanotide, targets the MC4R pathway to treat certain rare genetic forms of severe obesity and related neuroendocrine disorders. Rhythm advances therapies through clinical development and commercialization while partnering with clinicians, payers, and patient communities to expand access and support long‑term care.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Rhythm Pharmaceuticals.
Rhythm Pharmaceuticals didn’t post a salary, so this is our estimate from similar listings.
Medical Director, Medical Affairs
Regeneron Pharmaceuticals
Medical Science Liaison
Kinetic Business Solutions
Rare Disease & Oncology Medical Affairs Manager
AstraZeneca
Medical Science Liaison (MSL)
Sobi
Medical Science Liaison Manager - Rare Disease (f/m/d)
Ipsen
Rare Disease Oncology Medical Affairs Manager Barcelona Spain
AstraZeneca